D. Maclaren

发表

Letter: Pyelonephritis and coliform infections of the urinary tract.

D. MacLaren, D. Maclaren, 1975, Lancet.

Virulence of Escherichia coli in experimental hematogenous pyelonephritis in mice

J. de Graaff, D. MacLaren, J. F. van den Bosch, 1979, Infection and immunity.

Production, characterization and biological effects of monoclonal antibodies to different parts of the gram-negative lipopolysaccharide core region.

H. Brade, B. Appelmelk, J. Maaskant, 1988, Progress in clinical and biological research.

Measurement in human sera of antibodies to lipopolysaccharide of Escherichia coli J5.

B. Appelmelk, J. Maaskant, B. Thijs, 1987, Microbial pathogenesis.

Monoclonal antibodies detecting novel structures in the core region of Salmonella minnesota lipopolysaccharide

L. Thijs, B. Appelmelk, J. Maaskant, 1987 .

Use of mucin and hemoglobin in experimental murine Gram-negative bacteremia enhances the immunoprotective action of antibodies reactive with the lipopolysaccharide core region

B. Appelmelk, J. Maaskant, A. M. V. Verwey-van Vught, 2004, Antonie van Leeuwenhoek.

Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.

B. Appelmelk, J. Maaskant, A. V. Verweij-van Vught, 1988, Journal of medical microbiology.

Cross-reactivity of antibodies to lipopolysaccharides from Escherichia coli J5.

B. Appelmelk, J. Maaskant, A. V. Verweij-van Vught, 1986, Journal of Infectious Diseases.

Binding studies of a monoclonal antibody specific for 3-deoxy-D-manno-octulosonic acid with a panel of Klebsiella pneumoniae lipopolysaccharides representing all of the O serotypes

B. Appelmelk, J. de Graaff, A. V. Verweij-van Vught, 1994, Infection and immunity.

AMPICILLIN A BROAD-SPECTRUM PENICILLIN

R. Knox, J. Trafford, R. D. Barnes, 1962 .

The significance of urease in proteus pyelonephritis: a bacteriological study.

D. MacLaren, D. Maclaren, 1968, The Journal of pathology and bacteriology.

Prevention of lethal endotoxemia in actinomycin D-sensitized mice by incubation of Salmonella minnesota R595 lipopolysaccharide with monoclonal antibodies to R595.

H. Brade, B. Appelmelk, J. Maaskant, 1988, Microbial pathogenesis.

Virulence ofEscherichia coli strains isolated from urine of patients with acute cystitis and from faeces of healthy women

J. F. Bosch, P. Guiñee, J. Graaff, 2006, Antonie van Leeuwenhoek.

Uropathogenic properties of Proteus mirabilis and Proteus vulgaris.

D. MacLaren, P. Peerbooms, A. Verweij, 1985, Journal of medical microbiology.

Haemolysis by urinary Escherichia coli and virulence in mice.

J. de Graaff, D. MacLaren, J. F. van den Bosch, 1981, Journal of medical microbiology.

Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins.

B. Appelmelk, J. Maaskant, A. V. Verweij-van Vught, 1993, Journal of general microbiology.

LOCALISATION OF URINARY-TRACT INFECTION WITH URINARY LACTIC DEHYDROGENASE ISOENZYME 5

B. Appelmelk, D. Maclaren, 1981, The Lancet.

Sulphadimidine and nalidixic acid therapy in urinary-tract infections in general practice.

M. Donaghy, D. Maclaren, P. Brown, 1971, The Practitioner.

Frequencies of lipopolysaccharide core types in Escherichia coli strains from bacteraemic patients.

B. Appelmelk, Y. An, D. MacLaren, 1994, Microbiology.

HETEROGENEITY OF ESCHERICHIA COLI J5 VACCINES

B. Appelmelk, J. Maaskant, P. Peerbooms, 1986, The Lancet.

Recombinant human bactericidal/permeability-increasing protein (rBPI23) is a universal lipopolysaccharide-binding ligand

B. Appelmelk, J. de Graaff, Y. An, 1994, Infection and immunity.

Urinary Tract Infection

M. Donaghy, D. Maclaren, P. Brown, 1968 .

Plasmid content and virulence properties of urinary Escherichia coli strains

C. Waalwijk, J. F. Bosch, J. Graaff, 1982 .

Taxonomy of coagulase-negative staphylococci: a comparison of two widely used classification schemes

D. MacLaren, J. Graaff, F. Namavar, 2004, Antonie van Leeuwenhoek.

HALF-LIFE OF HBs ANTIBODY AFTER HEPATITIS B VACCINATION: AN AID TO TIMING OF BOOSTER VACCINATION

D. MacLaren, F. E. Nommensen, S. Go, 1989, The Lancet.

Phagocytosis and intracellular killing of coagulase-negative staphylococci

J. Graaff, F. Namavar, D. Maclaren, 1979, Medical Microbiology and Immunology.

Lactoferrin is a lipid A-binding protein

B. Appelmelk, J. de Graaff, M. Geerts, 1994, Infection and immunity.

Serotyping and Genotyping of GenitalChlamydia trachomatis Isolates Reveal Variants of Serovars Ba, G, and J as Confirmed by omp1 Nucleotide Sequence Analysis

J. Walboomers, S. Morré, C. Meijer, 1998, Journal of Clinical Microbiology.

Concentrations of ampicillin in pleural fluid and serum after single and repetitive doses of bacampicillin.

J. Stam, W. Bronsveld, D. Maclaren, 1978, Scandinavian Journal of Infectious Diseases. Supplementum.

Investigation of the haemolytic activity of Proteus mirabilis strains

D. MacLaren, P. Peerbooms, A. Verweij, 1983, Antonie van Leeuwenhoek.

Vero cell invasiveness of Proteus mirabilis

D. MacLaren, P. Peerbooms, A. Verweij, 1984, Infection and immunity.

Polymyxin B-horseradish peroxidase conjugates as tools in endotoxin research.

B. Appelmelk, A. V. Verweij-van Vught, B. Thijs, 1992, Analytical biochemistry.

Mannose-sensitive and mannose-resistant adherence to human uroepithelial cells and urinary virulence of Escherichia coli.

J. de Graaff, D. MacLaren, J. F. van den Bosch, 1980, Infection and immunity.

In vivo function of hemolysin in the nephropathogenicity of Escherichia coli

C. Waalwijk, J. de Graaff, D. MacLaren, 1983, Infection and immunity.

Virulence of urinary and faecal Escherichia coli in relation to serotype, haemolysis and haemagglutination

J. de Graaff, P. Guiñee, J. F. van den Bosch, 1982, Journal of Hygiene.

Murine ascitic fluids contain varying amounts of an inhibitor that interferes with complement-mediated effector functions of monoclonal antibodies.

B. Appelmelk, J. Maaskant, A. V. Verweij-van Vught, 1992, Immunology letters.

Influence of rosmarinic acid on opsonization and intracellular killing ofEschericha coli andStaphylococcus aureus by porcine and human polymorphonuclear leucocytes

A. Groeneveld, B. Appelmelk, M. Sparrius, 1987, Agents and Actions.

[Successful culture of Chlamydia pneumoniae in 2 asymptomatic patients].

E. Stolz, J. Kock, H. Tjhie, 1994, Nederlands tijdschrift voor geneeskunde.

Physical mapping of hemolysin plasmid pCW2, which codes for virulence of a nephropathogenic Escherichia coli strain

C. Waalwijk, J. de Graaff, D. Maclaren, 1984, Journal of bacteriology.

Comparison of monoclonal antibodies to the deeper core region of gram-negative lipopolysaccharide by means of polymyxin B inhibition studies.

B. Appelmelk, J. Maaskant, A. V. Verweij-van Vught, 1988, Microbial Pathogenesis.

Physical mapping of hemolysin plasmid pCW2, which codes for virulence of a nephropathogenic Escherichia coli strain

C. Waalwijk, D. Maclaren, J. D. Graaff, 1984, Journal of bacteriology.

Direct detection and genotyping of Chlamydia trachomatis in cervical scrapes by using polymerase chain reaction and restriction fragment length polymorphism analysis

J. Walboomers, A. V. D. van den Brule, C. Meijer, 1993, Journal of clinical microbiology.

Effect of the pH on the hemolytic titer of Escherichia coli strains

C. Waalwijk, D. MacLaren, J. Graaff, 1983 .

Determination of the α‐Haemolytic activity of haemolytic urinary Escherichia coli strains

J. F. Bosch, J. Graaff, P. Postma, 1980 .

β-Haemolysis by Streptococcus mutans

J. Graaff, J. Woltjes, D. Maclaren, 2004, Antonie van Leeuwenhoek.

Urinary pathogenicity of Proteus mirabilis strains isolated from faeces or urine

D. MacLaren, P. Peerbooms, A. Verweij, 2004, Antonie van Leeuwenhoek.

Urinary virulence of Proteus mirabilis in two experimental mouse models

J. Verweij, D. MacLaren, P. Peerbooms, 1982, Infection and immunity.

Virulence of Escherichia coli in acute pyelonephritis, acute cystitis and asymptomatic bacteriuria

J. F. Bosch, W. Jansen, P. Guiñee, 2004, Antonie van Leeuwenhoek.

BRL 1621: A Comparison with Other Isoxazolyl Penicillins

R. Knox, J. Smith, J. Trafford, 1962, British medical journal.